Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) EBT Margin (2020 - 2026)

Journey Medical filings provide 6 years of EBT Margin readings, the most recent being 8.07% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 2060.0% to 8.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 18.75%, a 775.0% increase, with the full-year FY2025 number at 18.57%, up 793.0% from a year prior.
  • EBT Margin hit 8.07% in Q4 2025 for Journey Medical, up from 13.6% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 110.5% in Q3 2023 to a low of 99.99% in Q2 2021.
  • Median EBT Margin over the past 5 years was 27.95% (2025), compared with a mean of 32.69%.
  • Biggest five-year swings in EBT Margin: soared 17299bps in 2023 and later plummeted -12684bps in 2024.
  • Journey Medical's EBT Margin stood at 76.59% in 2021, then fell by -4bps to 79.97% in 2022, then soared by 83bps to 13.22% in 2023, then surged by 195bps to 12.54% in 2024, then plummeted by -164bps to 8.07% in 2025.
  • The last three reported values for EBT Margin were 8.07% (Q4 2025), 13.6% (Q3 2025), and 24.89% (Q2 2025) per Business Quant data.